Goleta-based Sientra’s third quarter revenues down
Sientra Inc. sales were down 6.9 percent in the third quarter of 2015 but the results were largely unaffected by recent pandemonium at the company. The Goleta-based company reported third quarter results on Nov. 16 for the quarter that ended on Sept. 30, just one week after European regulators pulled products made by Sientra’s Brazilian Read More →
Goleta breast implant maker Sientra shakes up C-Suite
The writing was on the wall at Sientra. On Nov. 12, the company’s top executives took the fall. The embattled Goleta-based breast implant manufacturer cleaned house Thursday afternoon. Sientra founder and CEO Hani Zeini stepped down as CEO and he will be replaced by industry veteran Jeffrey Nugent. Nicholas Simon also resigned as chairman Read More →
Inogen’s third quarter earnings beat Wall Street expectations
Inogen, a Goleta-based maker of direct-to-consumer respiratory products, beat analyst estimates for revenue when the company released third quarter earnings on Nov. 10. Revenues were up 38.7 percent from $29.4 million during the third quarter of last year to $40.8 million this year. Analysts had predicted revenues of $37 million. Inogen also reported adjusted Read More →
FDA to review Amgen’s new kidney disease dug
Thousand Oaks-based biotech giant Amgen announced on Nov. 6 that the Food and Drug Administration will review a new treatment for patients with chronic kidney disease. The new drug, Etelcalcetide, works by suppressing the secretion of a parathyroid hormone. The drug is administered intravenously three times per week at the end of a dialysis session. Read More →
Goleta’s Sientra reassures investors, surgeons
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
